GlassScriptPhysician profile
Ryan Coelho
NPI 1043703200
$4,488.35
in general payments reported to CMS, 2019-2025
33 companies · $934 in 2025
The $934 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.86 · 2021: $709 · 2022: $1,159 · 2023: $892 · 2024: $779 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,605.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $849.63 | 2021-2025 | |
| Novo Nordisk INC | $672.77 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $611.01 | 2021-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $499.95 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.64 | 2021-2025 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $269.47 | 2021-2025 | Gardasil 9, Gardasil, Capvaxive |
| Glaxosmithkline, LLC. | $219.40 | 2021-2023 | Shingrix |
| Exact Sciences Corporation | $185.79 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $94.96 | 2023-2025 | Spravato |
| Lilly USA, LLC | $93.21 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $88.45 | 2021-2022 | |
| Seqirus USA INC | $85.54 | 2022-2025 | Fluad, Flucelvax, Flucelvax Quadrivalent |
| Astrazeneca Pharmaceuticals LP | $74.71 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Kowa Pharmaceuticals America, INC. | $74.25 | 2021-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $44.92 | 2021-2023 | Entresto, Leqvio |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $44.46 | 2021-2023 | Prolastin-C Liquid |
| Upsher-Smith Laboratories LLC | $28.89 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $25.86 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.11 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $19.10 | 2025 | Evkeeza |
| Corcept Therapeutics | $17.71 | 2025 | Korlym |
| Harmony Biosciences LLC | $17.32 | 2024 | |
| Sanofi Pasteur INC. | $17.00 | 2022 | |
| Althera Pharmaceuticals LLC | $15.18 | 2021 | |
| Amarin Pharma, INC. | $14.86 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.78 | 2023 | Strensiq |
| Takeda Pharmaceuticals U.S.A., INC. | $14.51 | 2023 | Vpriv |
| Nestle Healthcare Nutrition INC. | $14.04 | 2021 | |
| Irhythm Technologies, INC. | $14.01 | 2021 | |
| Cranial Technologies, INC | $14.00 | 2022 | |
| Cequr Corporation | $12.56 | 2022 | |
| Genentech USA, INC. | $11.17 | 2021 | |
| Medtronic, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Coelho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.